Abstract
Donor leukocyte infusion (DLI) was carried out on a 12-year-old girl with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) who received allogeneic bone marrow transplantation from an HLA-identical sibling. This is the first report of DLI use before the onset of hematological relapse monitored by the results of RT-PCR. This patient has been in CR for 11 months after BMT, suggesting this alternative treatment is promising for Ph + ALL with positive reverse transcriptase-polymerase chain reaction (RT-PCR) following BMT.
| Original language | English |
|---|---|
| Pages (from-to) | 393-394 |
| Number of pages | 2 |
| Journal | Bone Marrow Transplantation |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 02-02-1997 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Hematology
- Transplantation
Cite this
}
Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion. / Yazaki, M.; Andoh, M.; Ito, Tetsuya; Ohno, T.; Wada, Y.
In: Bone Marrow Transplantation, Vol. 19, No. 4, 02.02.1997, p. 393-394.Research output: Contribution to journal › Article
TY - JOUR
T1 - Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion
AU - Yazaki, M.
AU - Andoh, M.
AU - Ito, Tetsuya
AU - Ohno, T.
AU - Wada, Y.
PY - 1997/2/2
Y1 - 1997/2/2
N2 - Donor leukocyte infusion (DLI) was carried out on a 12-year-old girl with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) who received allogeneic bone marrow transplantation from an HLA-identical sibling. This is the first report of DLI use before the onset of hematological relapse monitored by the results of RT-PCR. This patient has been in CR for 11 months after BMT, suggesting this alternative treatment is promising for Ph + ALL with positive reverse transcriptase-polymerase chain reaction (RT-PCR) following BMT.
AB - Donor leukocyte infusion (DLI) was carried out on a 12-year-old girl with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) who received allogeneic bone marrow transplantation from an HLA-identical sibling. This is the first report of DLI use before the onset of hematological relapse monitored by the results of RT-PCR. This patient has been in CR for 11 months after BMT, suggesting this alternative treatment is promising for Ph + ALL with positive reverse transcriptase-polymerase chain reaction (RT-PCR) following BMT.
UR - http://www.scopus.com/inward/record.url?scp=0031059857&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031059857&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1700663
DO - 10.1038/sj.bmt.1700663
M3 - Article
VL - 19
SP - 393
EP - 394
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
SN - 0268-3369
IS - 4
ER -